Pathstone Family Office’s Sanofi SNY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | $834K | Buy |
15,550
+5,815
| +60% | +$312K | 0.01% | 797 |
|
|
2023
Q2 | $542K | Buy |
9,735
+3,325
| +52% | +$185K | 0.01% | 719 |
|
|
2023
Q1 | $361K | Sell |
6,410
-23,514
| -79% | -$1.32M | 0.01% | 832 |
|
|
2022
Q4 | $995K | Buy |
29,924
+8,304
| +38% | +$276K | 0.01% | 798 |
|
|
2022
Q3 | $839K | Buy |
21,620
+13,129
| +155% | +$509K | 0.01% | 831 |
|
|
2022
Q2 | $425K | Buy |
8,491
+3,674
| +76% | +$184K | 0.01% | 646 |
|
|
2022
Q1 | $258K | Sell |
4,817
-342
| -7% | -$18.3K | 0.01% | 804 |
|
|
2021
Q4 | $258K | Sell |
5,159
-432
| -8% | -$21.6K | 0.01% | 755 |
|
|
2021
Q3 | $269K | Buy |
5,591
+927
| +20% | +$44.6K | 0.01% | 711 |
|
|
2021
Q2 | $246K | Buy |
+4,664
| New | +$246K | 0.01% | 706 |
|
|
2021
Q1 | – | Sell |
-645
| Closed | -$31K | – | 1232 |
|
|
2020
Q4 | $31K | Sell |
645
-409
| -39% | -$19.7K | ﹤0.01% | 595 |
|
|
2020
Q3 | $53K | Buy |
1,054
+409
| +63% | +$20.6K | 0.01% | 362 |
|
|
2020
Q2 | $33K | Buy |
+645
| New | +$33K | ﹤0.01% | 366 |
|
|
2018
Q2 | – | Sell |
-227
| Closed | -$9K | – | 307 |
|
|
2018
Q1 | $9K | Buy |
+227
| New | +$9K | 0.01% | 238 |
|
|
2017
Q3 | – | Sell |
-712
| Closed | -$34K | – | 316 |
|
|
2017
Q2 | $34K | Hold |
712
| – | – | 0.01% | 237 |
|
|
2017
Q1 | $32K | Buy |
+712
| New | +$32K | 0.02% | 210 |
|
|
2013
Q3 | – | Sell |
-64
| Closed | -$3K | – | 411 |
|
|
2013
Q2 | $3K | Buy |
+64
| New | +$3K | ﹤0.01% | 318 |
|